Swiss pharma companies likely to follow Pfizer-U.S. price deal, says business lobby
辉瑞辉瑞(US:PFE) Reuters·2025-10-01 19:09

行业趋势 - 瑞士制药公司可能效仿辉瑞与美国达成的药品定价协议 [1] - 此趋势源于特朗普政府要求降低药品价格的压力 [1]